Keith Crawford’s December appointment as President of Provider Network Holdings represents the culmination of a 15-year trajectory through specialty pharmacy and infusion services. His progression reveals consistent patterns: building operational infrastructure, scaling healthcare platforms, and developing physician network relationships that now position him to lead a comprehensive specialty healthcare services company.
Foundation: Clinical Trials and Home Infusion Leadership
Crawford’s career foundation emerged at Coram Healthcare, where he served as Senior Vice President of Marketing and Legislative Affairs while simultaneously leading the Clinical Trials Division from 2008 to 2012. This dual responsibility provided early exposure to both commercial healthcare operations and the regulatory demands that characterize specialty pharmaceutical services.
The Coram experience established critical competencies: understanding payor dynamics, managing clinical protocols, and coordinating intricate distribution networks for biologic medications. These capabilities became increasingly valuable as the specialty pharmaceutical sector matured and biologics proliferated across therapeutic areas.
Platform Building: MSD and Preferred Homecare
Crawford transitioned to Medical Specialties Distributors in 2016, assuming responsibility for infusion operations and enterprise direction as Executive Vice President. MSD’s business model—serving home infusion pharmacies, compounding facilities, specialty pharmacies, and oncology markets—required sophisticated logistics and deep manufacturer relationships.
His earlier role at Preferred Homecare (2014-2016) as Executive Vice President of Operations provided parallel experience in home-based care delivery. Together, these positions developed Crawford’s understanding of non-hospital specialty pharmaceutical distribution, a segment experiencing substantial growth as cost pressures drive care migration from institutional settings.
Executive Maturation: Solara Medical Supplies
Crawford advanced to CEO and President of Pharmacy Operations at Solara Medical Supplies in 2018, leading the nation’s largest independent diabetes medical device and supply distributor. This role expanded his scope beyond infusion services to encompass broader pharmaceutical distribution and patient support programs.
Solara’s scale and independence offered lessons in maintaining competitive positioning without health system or insurance company backing—experience directly relevant to Provider Network Holdings’ mission of supporting independent specialty physicians.
CarepathRx: Integrated Health System Solutions
As President of Specialty Pharmacy & Infusion Solutions at CarepathRx, Crawford oversaw operations serving over 600 hospitals before the company’s acquisition by Evernorth Health Services. CarepathRx’s partnerships with Yale New Haven Health, UPMC, and Jackson Hospital demonstrated his capability in designing turnkey specialty pharmacy and home infusion programs for sophisticated health systems.
Provider Network Holdings: Platform Integration Opportunity
PNH offers Crawford a distinct challenge: integrating four established businesses—Altus Biologics, Remedy GPO, Cornerstone Specialty Network, and Health Coalition—into a cohesive platform serving 2,000+ providers across multiple specialties.
Waud Capital Partners, founded by Reeve B. Waud in 1993, brings healthcare platform development expertise honed across investments including Acadia Healthcare, which Waud established in 2005 and guided to a successful 2011 IPO. Acadia’s growth from startup to a behavioral health platform operating 260+ facilities demonstrates the firm’s capability in building healthcare services companies through operational excellence and disciplined acquisition programs.
Read: Waud Capital Partners Announces Three Partner Promotions and One Principal Promotion